Dipharma Francis S.R.L. | Date: 2014-06-02
A process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine) or a pharmaceutically acceptable salt thereof having low content in impurities.
Dipharma Francis S.R.L. | Date: 2014-10-03
The present invention relates to the acetate salt of Mirabegron, in particular in two novel crystalline forms, a process for their preparation and the use of said salt and its crystalline forms in the synthesis of Mirabegron with high yields and chemical purity.
Dipharma Francis S.R.L. | Date: 2014-04-08
Process for the preparation of intermediates that are useful in the synthesis of active pharmaceutical ingredients (API), in particular active in the central nervous system.
DIPHARMA FRANCIS S.r.l. | Date: 2014-10-10
Dipharma Francis S.r.l. | Date: 2015-06-23
Substantially stable to degradation Fesoterodine fumarate, a process for its preparation and a process for the synthesis of specific degradation impurities of Fesoterodine fumarate are disclosed.